Results 81 to 90 of about 6,160,477 (183)
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma. [PDF]
In GK +17 more
europepmc +1 more source
A Case of Metastatic Basal Cell Carcinoma (BCC) With Spinal and Pulmonary Metastases Treated With Vismodegib, Sonedigib, and Radiotherapy. [PDF]
Samia AM, Nenow JM, Boyer P.
europepmc +1 more source
Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma
<b><i>Background:</i></b> Metastatic basal cell carcinoma is rare and the prognosis is poor, with a lack of established treatment options for patients progressing on or after treatment with inhibitors of the hedgehog signaling ...
Thomas Kluckert +5 more
core +1 more source
Basal Cell Carcinoma of the Scalp with Lung, Bone and Lymph Node Metastasis in a Korean Woman [PDF]
Metastatic basal cell carcinoma (MBCC) is very rare with incidences estimated to range from 0.0028% to 0.5% in the Caucasian population. The incidence of basal cell carcinoma is known to be much lower in Asian populations including Koreans.
김종훈, 노미령, 이상희
core
A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel
Chryssoula Papageorgiou +5 more
doaj +1 more source
Multiple primary neoplasms may also occur synchronously. Lymphoma may coexist with second malignant tumor in its primary location or malignant tumor may metastases to lymphomatous lymph nodes.
Monika Prochorec-Sobieszek +2 more
core +1 more source
Basosquamous carcinoma (BSC) is a rare cutaneous malignancy, with mixed morphology of both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
Sajjad Ahmad Baloch
doaj
18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma. [PDF]
Jadvar H, In GK.
europepmc +1 more source
Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma
Globally, basal cell carcinoma is the most commonly diagnosed cancer. While most cases are amenable to surgery, treatment options for advanced basal cell carcinoma, including locally advanced basal cell carcinoma and metastatic basal cell carcinoma, have
Gutzmer, Ralf, Solomon, James A.
core +1 more source
Basal cell carcinoma (BCC) is one of the most common skin malignancies worldwide. Morpheaform basal cell carcinoma (MBCC) is a rare aggressive subtype of BCC that presents with unique histologic features. Both are treated surgically and have an excellent
Sulaimann, Abdullahi +4 more
core +1 more source

